KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Accounts Payables: 2009-2024

Historic Accounts Payables for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $1.4 billion.

  • Quest Diagnostics' Accounts Payables rose 10.97% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 10.97%. This contributed to the annual value of $1.4 billion for FY2024, which is 2.58% up from last year.
  • Latest data reveals that Quest Diagnostics reported Accounts Payables of $1.4 billion as of FY2024, which was up 2.58% from $1.4 billion recorded in FY2023.
  • In the past 5 years, Quest Diagnostics' Accounts Payables ranged from a high of $1.6 billion in FY2020 and a low of $1.4 billion during FY2023.
  • Moreover, its 3-year median value for Accounts Payables was $1.4 billion (2024), whereas its average is $1.4 billion.
  • In the last 5 years, Quest Diagnostics' Accounts Payables surged by 56.87% in 2020 and then declined by 12.75% in 2022.
  • Over the past 5 years, Quest Diagnostics' Accounts Payables (Yearly) stood at $1.6 billion in 2020, then decreased by 2.02% to $1.6 billion in 2021, then fell by 12.75% to $1.4 billion in 2022, then declined by 2.65% to $1.4 billion in 2023, then increased by 2.58% to $1.4 billion in 2024.